CN115337442A - A kind of medical adhesive glue and its preparation method and application - Google Patents
A kind of medical adhesive glue and its preparation method and application Download PDFInfo
- Publication number
- CN115337442A CN115337442A CN202110529414.3A CN202110529414A CN115337442A CN 115337442 A CN115337442 A CN 115337442A CN 202110529414 A CN202110529414 A CN 202110529414A CN 115337442 A CN115337442 A CN 115337442A
- Authority
- CN
- China
- Prior art keywords
- medical adhesive
- parts
- polyethylene glycol
- mixed solution
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000853 adhesive Substances 0.000 title claims abstract description 112
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 112
- 238000002360 preparation method Methods 0.000 title claims abstract description 45
- 239000003292 glue Substances 0.000 title claims description 30
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 53
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 53
- 239000011259 mixed solution Substances 0.000 claims abstract description 43
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 25
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 22
- 238000004132 cross linking Methods 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 20
- 239000000872 buffer Substances 0.000 claims abstract description 18
- -1 acrylic compound Chemical class 0.000 claims abstract description 16
- 239000003431 cross linking reagent Substances 0.000 claims abstract description 16
- 239000003999 initiator Substances 0.000 claims abstract description 15
- 210000001519 tissue Anatomy 0.000 claims abstract description 13
- 239000002562 thickening agent Substances 0.000 claims abstract description 9
- 210000004872 soft tissue Anatomy 0.000 claims abstract description 7
- 238000007789 sealing Methods 0.000 claims abstract description 6
- 239000003937 drug carrier Substances 0.000 claims abstract description 5
- 230000008439 repair process Effects 0.000 claims abstract description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 12
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical group [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- 238000006392 deoxygenation reaction Methods 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 8
- 125000004386 diacrylate group Chemical group 0.000 claims description 8
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 7
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 claims description 7
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 7
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Chemical compound CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 claims description 7
- 235000010413 sodium alginate Nutrition 0.000 claims description 7
- 239000000661 sodium alginate Substances 0.000 claims description 7
- 229940005550 sodium alginate Drugs 0.000 claims description 7
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 4
- 239000011837 N,N-methylenebisacrylamide Substances 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 4
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000002439 hemostatic effect Effects 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 2
- 238000012805 post-processing Methods 0.000 claims description 2
- 210000001835 viscera Anatomy 0.000 claims description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 abstract description 23
- 230000023597 hemostasis Effects 0.000 abstract description 3
- 230000009278 visceral effect Effects 0.000 abstract description 3
- 230000000052 comparative effect Effects 0.000 description 15
- 206010052428 Wound Diseases 0.000 description 13
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 238000012360 testing method Methods 0.000 description 9
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 6
- 238000005452 bending Methods 0.000 description 6
- 229920001651 Cyanoacrylate Polymers 0.000 description 5
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 5
- 239000000017 hydrogel Substances 0.000 description 5
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 229960000907 methylthioninium chloride Drugs 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229960003638 dopamine Drugs 0.000 description 2
- 230000000214 effect on organisms Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920001690 polydopamine Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical compound OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 description 1
- GJKGAPPUXSSCFI-UHFFFAOYSA-N 2-Hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone Chemical compound CC(C)(O)C(=O)C1=CC=C(OCCO)C=C1 GJKGAPPUXSSCFI-UHFFFAOYSA-N 0.000 description 1
- IJVRPNIWWODHHA-UHFFFAOYSA-N 2-cyanoprop-2-enoic acid Chemical compound OC(=O)C(=C)C#N IJVRPNIWWODHHA-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 239000004830 Super Glue Substances 0.000 description 1
- ZZAGLMPBQOKGGT-UHFFFAOYSA-N [4-[4-(4-prop-2-enoyloxybutoxy)benzoyl]oxyphenyl] 4-(4-prop-2-enoyloxybutoxy)benzoate Chemical compound C1=CC(OCCCCOC(=O)C=C)=CC=C1C(=O)OC(C=C1)=CC=C1OC(=O)C1=CC=C(OCCCCOC(=O)C=C)C=C1 ZZAGLMPBQOKGGT-UHFFFAOYSA-N 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- AEDZKIACDBYJLQ-UHFFFAOYSA-N ethane-1,2-diol;hydrate Chemical compound O.OCCO AEDZKIACDBYJLQ-UHFFFAOYSA-N 0.000 description 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- ZLMJMSJWJFRBEC-AKLPVKDBSA-N potassium-42 Chemical group [42K] ZLMJMSJWJFRBEC-AKLPVKDBSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/104—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明提供一种医用粘合胶及其制备方法和应用。所述医用粘合胶的制备原料包括如下重量份数的组分:丙烯酸酯类聚乙二醇6‑50份、丙烯酸类化合物0.2‑35份、交联剂0.001‑1份和碱性缓冲剂0.1‑3份。首先将丙烯酸酯类聚乙二醇、丙烯酸类化合物、交联剂、引发剂和水混合,得到混合溶液A;将增稠剂和水混合,得到混合溶液B;之后将溶液A和B混合,通过碱性缓冲剂调节混合溶液的pH为6‑7之间后,进行交联反应,得到所述医用粘合胶。所述医用粘合胶具有较高的粘附强度、较好的贴合性及良好的生物相容性和可降解性,可用于创面止血、内脏及软组织伤口封合和堵漏、纤维环断裂的修复或组织工程的药物载体。
The invention provides a medical adhesive, a preparation method and application thereof. The raw materials for the preparation of the medical adhesive include the following components in parts by weight: 6-50 parts of acrylate polyethylene glycol, 0.2-35 parts of acrylic compound, 0.001-1 part of crosslinking agent and alkaline buffer 0.1‑3 servings. First, mix acrylate polyethylene glycol, acrylic compound, crosslinking agent, initiator and water to obtain mixed solution A; mix the thickener and water to obtain mixed solution B; then mix solutions A and B, After the pH of the mixed solution is adjusted to be between 6-7 by an alkaline buffer, a cross-linking reaction is performed to obtain the medical adhesive. The medical adhesive has high adhesion strength, good fit, good biocompatibility and degradability, and can be used for wound hemostasis, visceral and soft tissue wound sealing and plugging, fibrous annulus fracture Drug carrier for repair or tissue engineering.
Description
技术领域technical field
本发明属于生物医用材料技术领域,具体涉及一种医用粘合胶及其制备方法和应用。The invention belongs to the technical field of biomedical materials, and in particular relates to a medical adhesive and its preparation method and application.
背景技术Background technique
医学临床上常用手术缝合线或皮肤吻合器连接破裂的组织,以恢复机体正常的结构和运行功能。传统吻合器的使用复杂费时,而缝线材料由于切口缝合过紧容易引起局部组织缺血,导致周围组织发炎、结节增生或术后瘢痕等。随着经济水平的快速发展及医疗卫生事业的推动,患者对手术服务及术后创面外观的需求不断提高。近年来,生物医用粘合胶的研发及产业化得到了快速的发展。医用粘合胶能快速固化成膜并与创面镶嵌紧密,可牢固地保持伤口的对合状态,减少伤口的出血和感染几率,具有控制出血、闭合伤口和抑制瘢痕增生等功效。Surgical sutures or skin staplers are commonly used in clinical medicine to connect ruptured tissues to restore the normal structure and function of the body. The use of traditional staplers is complicated and time-consuming, and the suture material is likely to cause local tissue ischemia due to tight incision suturing, resulting in inflammation of surrounding tissues, nodular hyperplasia, or postoperative scars. With the rapid development of the economy and the promotion of medical and health services, patients' demand for surgical services and the appearance of postoperative wounds continues to increase. In recent years, the research and development and industrialization of biomedical adhesives have developed rapidly. The medical adhesive can quickly solidify to form a film and be tightly inlaid with the wound surface, which can firmly maintain the apposition state of the wound, reduce the bleeding and infection chance of the wound, and have the functions of controlling bleeding, closing the wound and inhibiting scar hyperplasia.
CN103585671A公开了一种氰基丙烯酸酯医用粘合剂。所述氰基丙烯酸酯粘合剂包括以下质量百分含量的组分:氰基丙烯酸酯80-95%、柠檬酸酯2-10%、甲醛抑制剂2-8%、对苯二酚0.1-0.5%和二氧化硫稳定剂0.1-1.0%;所述氰基丙烯酸酯医用粘合剂的制备方法为:按质量比准确称量氰基丙烯酸酯和柠檬酸酯并混合,加入甲醛抑制剂及对苯二酚充分搅拌后通入二氧化硫稳定剂,制备得到氰基丙烯酸酯医用胶。该技术方案制备得到的粘合剂虽然具有较好的黏结强度,但是生物相容性较差。CN103585671A discloses a cyanoacrylate medical adhesive. The cyanoacrylate adhesive includes the following components in mass percentage: cyanoacrylate 80-95%, citric acid ester 2-10%, formaldehyde inhibitor 2-8%, hydroquinone 0.1- 0.5% and sulfur dioxide stabilizer 0.1-1.0%; the preparation method of the cyanoacrylate medical adhesive is: accurately weigh cyanoacrylate and citrate according to the mass ratio and mix them, add formaldehyde inhibitor and p-benzene After the diphenol is fully stirred, a sulfur dioxide stabilizer is added to prepare the cyanoacrylate medical glue. Although the adhesive prepared by this technical scheme has good bonding strength, its biocompatibility is poor.
CN111876104A公开了一种医用粘合胶及其制备工艺。所述医用粘合胶中包括如下重量份数的组分:α-氰基丙烯酸酯56份、二氧化硫0.1份、水性聚氨酯20份、芦荟提取物0.5份、多糖化合物1份、氨基化羧甲基壳聚糖0.2份、柠檬酸钠1份、松香1份、对苯二酚0.2份、聚乙二醇1份、去离子水20份、催化剂、脱水剂与增塑剂。该技术方案中,制备医用粘合剂的组分较复杂,制备得到所述粘合胶的工艺步骤较繁琐,且制备得到的粘合胶的力学强度较差。CN111876104A discloses a medical adhesive and its preparation process. The medical adhesive includes the following components in parts by weight: 56 parts of α-cyanoacrylate, 0.1 part of sulfur dioxide, 20 parts of water-based polyurethane, 0.5 part of aloe extract, 1 part of polysaccharide compound, aminated carboxymethyl 0.2 parts of chitosan, 1 part of sodium citrate, 1 part of rosin, 0.2 parts of hydroquinone, 1 part of polyethylene glycol, 20 parts of deionized water, catalyst, dehydrating agent and plasticizer. In this technical solution, the components for preparing the medical adhesive are relatively complicated, the process steps for preparing the adhesive are cumbersome, and the prepared adhesive has poor mechanical strength.
随着科学技术的发展,触感类似于生物软组织的粘性水凝胶代表了一类创新性的生物医用密封胶,因其能够促进伤口愈合和组织再生,在基础研究及临床应用皆得到广泛发展。例如,CN110484184A公开了一种水凝胶粘合剂及其制备方法与应用。所述水凝胶粘合剂包括A组分和B组分,A组分中的羟氨基与B组分中的醛基的摩尔比为1:1;A组分为溶有巯基封端的聚乙二醇嵌段聚合物的缓冲液;B组分为含有炔基封端的四臂聚乙二醇、明胶和聚多巴胺的缓冲液;所述制备方法包括如下步骤:(1)将巯基封端的聚乙二醇嵌段聚合物加入缓冲液中,惰性气氛下加热至完全溶解,得到A组分;(2)将多巴胺溶于缓冲液中,调节pH至11.0,室温下搅拌2-3h,使多巴胺聚合形成聚多巴胺,调节pH至7-8,加入炔基封端的四臂聚乙二醇和明胶,室温下搅拌均匀,得到B组分;(3)将A组分和B组分按照羟氨基与醛基的摩尔比为1:1分装,得到水凝胶粘合剂。在该技术方案中,制备巯基封端的聚乙二醇嵌段聚合物的步骤较复杂,由此使制备水凝胶粘合剂的方法复杂繁琐,不适于工业化生产。With the development of science and technology, viscous hydrogels that feel similar to biological soft tissues represent an innovative class of biomedical sealants. Because of their ability to promote wound healing and tissue regeneration, they have been widely developed in both basic research and clinical applications. For example, CN110484184A discloses a hydrogel adhesive and its preparation method and application. The hydrogel adhesive includes A component and B component, the molar ratio of the hydroxyl amino group in A component to the aldehyde group in B component is 1:1; The buffer solution of ethylene glycol block polymer; B component is the buffer solution containing four-arm polyethylene glycol, gelatin and polydopamine of alkyne end-capping; The preparation method comprises the following steps: (1) the sulfhydryl end-capping The polyethylene glycol block polymer is added to the buffer, and heated under an inert atmosphere until it is completely dissolved to obtain component A; (2) Dissolve dopamine in the buffer, adjust the pH to 11.0, and stir at room temperature for 2-3 hours to make Dopamine is polymerized to form polydopamine, adjust the pH to 7-8, add alkyne-terminated four-arm polyethylene glycol and gelatin, and stir evenly at room temperature to obtain component B; The molar ratio with the aldehyde group is 1:1, and the hydrogel adhesive is obtained. In this technical solution, the steps for preparing the mercapto-terminated polyethylene glycol block polymer are relatively complicated, which makes the method for preparing the hydrogel adhesive complicated and cumbersome, and is not suitable for industrial production.
为了提高粘合剂对组织的伤口修复力及后期愈合性,理想的医用粘合剂必须能够与软组织达到紧密贴合。因此,如何提供一种兼具力学强度和弯曲形变,且制备流程简易的医用粘合胶,已成为目前亟待解决的技术问题。In order to improve the wound repairing ability of the adhesive to the tissue and the later healing, the ideal medical adhesive must be able to achieve a close fit with the soft tissue. Therefore, how to provide a medical adhesive with both mechanical strength and bending deformation and a simple preparation process has become a technical problem to be solved urgently.
发明内容Contents of the invention
针对现有技术的不足,本发明的目的在于提供一种医用粘合胶及其制备方法和应用。本发明中通过对医用粘合胶原料组分的设计,制备得到的医用粘合胶具有较高的粘附强度、较好的贴合性以及良好的生物相容性和可降解性能,可实现伤口创面的封合等。Aiming at the deficiencies of the prior art, the object of the present invention is to provide a medical adhesive and its preparation method and application. In the present invention, through the design of the raw material components of the medical adhesive adhesive, the prepared medical adhesive adhesive has higher adhesion strength, better fit, good biocompatibility and degradability, and can realize Wound sealing, etc.
为达此目的,本发明采用以下技术方案:For reaching this purpose, the present invention adopts following technical scheme:
第一方面,本发明提供一种医用粘合胶,所述医用粘合胶的制备原料包括如下重量份数的组分:丙烯酸酯类聚乙二醇6-50份、丙烯酸类化合物0.2-35份、交联剂0.001-1份和碱性缓冲剂0.1-3份。In the first aspect, the present invention provides a medical adhesive, the raw materials for the preparation of the medical adhesive include the following components in parts by weight: 6-50 parts of acrylate polyethylene glycol, 0.2-35 parts of acrylic compound 0.001-1 part of cross-linking agent and 0.1-3 parts of alkaline buffer.
本发明中,通过对医用粘合胶原料组分的设计,进一步通过丙烯酸酯类聚乙二醇、丙烯酸类化合物和交联剂间的反应,制备得到了具有交联网状结构的医用粘合胶,使制备得到的医用粘合胶具有较高的粘附强度和力学强度,同时具有良好的生物相容性和生物可降解性能。In the present invention, through the design of the raw material components of the medical adhesive glue, and further through the reaction between the acrylate polyethylene glycol, the acrylic compound and the crosslinking agent, a medical adhesive glue with a cross-network structure is prepared. , so that the prepared medical adhesive has high adhesive strength and mechanical strength, and has good biocompatibility and biodegradability.
本发明中,所述丙烯酸酯类聚乙二醇的重量份数可以是6份、10份、15份、20份、25份、30份、35份、40份、45份或50份等。In the present invention, the weight parts of the acrylate polyethylene glycol can be 6 parts, 10 parts, 15 parts, 20 parts, 25 parts, 30 parts, 35 parts, 40 parts, 45 parts or 50 parts.
所述丙烯酸类化合物的重量份数可以是0.2份、1份、2份、5份、8份、10份、15份、17份、20份、22份、25份、27份、30份、33份或35份等。The parts by weight of the acrylic compound can be 0.2 parts, 1 part, 2 parts, 5 parts, 8 parts, 10 parts, 15 parts, 17 parts, 20 parts, 22 parts, 25 parts, 27 parts, 30 parts, 33 or 35 etc.
所述交联剂的重量份数可以是0.001份、0.005份、0.01份、0.02份、0.05份、0.1份、0.2份、0.3份、0.4份、0.5份、0.6份、0.7份、0.8份、0.9份或1份等。The parts by weight of the crosslinking agent can be 0.001 part, 0.005 part, 0.01 part, 0.02 part, 0.05 part, 0.1 part, 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.7 part, 0.8 part, 0.9 part or 1 part etc.
所述碱性缓冲剂的重量份数可以是0.1份、0.2份、0.5份、0.7份、1份、1.2份、1.5份、1.8份、2份、2.3份、2.5份、2.7份或3份等。The parts by weight of the alkaline buffering agent can be 0.1 part, 0.2 part, 0.5 part, 0.7 part, 1 part, 1.2 part, 1.5 part, 1.8 part, 2 parts, 2.3 parts, 2.5 parts, 2.7 parts or 3 parts Wait.
以下作为本发明的优选技术方案,但不作为对本发明提供的技术方案的限制,通过以下优选的技术方案,可以更好地实现本发明的目的和有益效果。The following are preferred technical solutions of the present invention, but not as limitations on the technical solutions provided by the present invention. Through the following preferred technical solutions, the purpose and beneficial effects of the present invention can be better realized.
作为本发明的优选技术方案,所述丙烯酸酯类聚乙二醇选自聚乙二醇甲醚甲基丙烯酸酯、聚乙二醇甲基丙烯酸酯、聚乙二醇二丙烯酸酯、聚乙二醇二甲基丙烯酸酯或甲氧基聚乙二醇丙烯酸酯中的任意一种或至少两种的组合。As a preferred technical solution of the present invention, the acrylate polyethylene glycol is selected from polyethylene glycol methyl ether methacrylate, polyethylene glycol methacrylate, polyethylene glycol diacrylate, polyethylene glycol Any one or a combination of at least two of alcohol dimethacrylate or methoxy polyethylene glycol acrylate.
优选地,所述丙烯酸酯类聚乙二醇的重均分子量为300-2000,例如可以是300、400、600、800、1000、1200、1400、1600、1800或2000等。Preferably, the weight-average molecular weight of the acrylate polyethylene glycol is 300-2000, for example, 300, 400, 600, 800, 1000, 1200, 1400, 1600, 1800 or 2000.
优选地,所述丙烯酸类化合物选自丙烯酸、甲基丙烯酸或2-乙基丙烯酸中的任意一种或至少两种化合物。Preferably, the acrylic compound is selected from any one or at least two compounds of acrylic acid, methacrylic acid or 2-ethylacrylic acid.
作为本发明的优选技术方案,所述交联剂选自聚乙二醇二丙烯酸酯、N,N-亚甲基双丙烯酰胺、聚乙二醇二甲基丙烯酸酯或乙二醇二甲基丙烯酸酯中的任意一种或至少两种的组合。As a preferred technical solution of the present invention, the crosslinking agent is selected from polyethylene glycol diacrylate, N,N-methylenebisacrylamide, polyethylene glycol dimethacrylate or ethylene glycol dimethyl Any one or a combination of at least two of acrylates.
优选地,所述交联剂的重均分子量为300-2000,例如可以是300、400、600、800、1000、1200、1400、1600、1800或2000等。Preferably, the cross-linking agent has a weight average molecular weight of 300-2000, for example, 300, 400, 600, 800, 1000, 1200, 1400, 1600, 1800 or 2000.
优选地,所述碱性缓冲剂选自氢氧化钠、碳酸氢钠或磷酸氢二钠中的任意一种或至少两种的组合。Preferably, the alkaline buffer is selected from any one or a combination of at least two of sodium hydroxide, sodium bicarbonate or disodium hydrogen phosphate.
优选地,所述碱性缓冲剂为碱性缓冲剂溶液。Preferably, the alkaline buffer is an alkaline buffer solution.
优选地,所述碱性缓冲剂溶液中碱性缓冲剂的质量百分含量为5-30%,例如可以是5%、7%、10%、12%、15%、18%、22%、25%、27%或30%等。Preferably, the mass percentage of alkaline buffer in the alkaline buffer solution is 5-30%, for example, it can be 5%, 7%, 10%, 12%, 15%, 18%, 22%, 25%, 27%, or 30%, etc.
作为本发明的优选技术方案,所述医用粘合胶的制备原料中还包括增稠剂1-15份,例如可以是1份、2份、3份、4份、5份、6份、7份、8份、9份、10份、11份、12份、13份、14份或15份等。As a preferred technical solution of the present invention, the raw materials for the preparation of the medical adhesive also include 1-15 parts of thickener, such as 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts or 15 parts etc.
优选地,所述增稠剂选自明胶和/或海藻酸钠。Preferably, the thickener is selected from gelatin and/or sodium alginate.
作为本发明的优选技术方案,所述医用粘合胶的制备原料中还包括引发剂0.001-1份,例如可以是0.001份、0.005份、0.01份、0.02份、0.05份、0.07份、0.1份、0.2份、0.3份、0.4份、0.5份、0.6份、0.7份、0.8份、0.9份或1份等。As a preferred technical solution of the present invention, the raw materials for the preparation of the medical adhesive also include 0.001-1 part of initiator, such as 0.001 part, 0.005 part, 0.01 part, 0.02 part, 0.05 part, 0.07 part, 0.1 part , 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1 etc.
优选地,所述引发剂选自热引发剂或光引发剂。Preferably, the initiator is selected from thermal initiators or photoinitiators.
优选地,所述热引发剂选自过硫酸铵和/或过硫酸钾。Preferably, the thermal initiator is selected from ammonium persulfate and/or potassium persulfate.
优选地,所述光引发剂选自2-羟基-4-(2-羟乙氧基)-2-甲基苯丙酮、2-苄基-2-二甲基氨基-1-(4-吗啉苯基)丁酮、偶氮二异丁眯盐酸盐或偶氮二异丁咪唑啉盐酸盐中的任意一种或至少两种的组合。Preferably, the photoinitiator is selected from 2-hydroxyl-4-(2-hydroxyethoxy)-2-methylpropiophenone, 2-benzyl-2-dimethylamino-1-(4-methanol Any one or a combination of at least two of phenyline phenyl) butanone, azobisisobutimidazoline hydrochloride or azobisisobutimidazoline hydrochloride.
优选地,所述医用粘合胶的制备原料中还包括50-99份水,例如可以是50份、55份、60份、65份、70份、75份、80份、85份、90份、95份或99份等。Preferably, the raw materials for the preparation of the medical adhesive also include 50-99 parts of water, such as 50 parts, 55 parts, 60 parts, 65 parts, 70 parts, 75 parts, 80 parts, 85 parts, 90 parts , 95 or 99 copies, etc.
第二方面,本发明提供一种如第一方面所述的医用粘合胶的制备方法,包括如下步骤:In a second aspect, the present invention provides a method for preparing a medical adhesive as described in the first aspect, comprising the steps of:
(1)将丙烯酸酯类聚乙二醇、丙烯酸类化合物、交联剂和水混合,得到混合溶液A;(1) Mix acrylate polyethylene glycol, acrylic compound, crosslinking agent and water to obtain mixed solution A;
将任选的增稠剂和水混合,得到混合溶液B;An optional thickener is mixed with water to obtain a mixed solution B;
(2)将步骤(1)得到的混合溶液A、混合溶液B、碱性缓冲剂和引发剂混合后,进行交联反应,得到所述医用粘合胶。(2) After mixing the mixed solution A, mixed solution B, alkaline buffer and initiator obtained in the step (1), carry out a crosslinking reaction to obtain the medical adhesive.
需要说明的是,碱性缓冲剂的使用可将步骤(2)所述混合后的混合溶液的pH调节至6-7,可与皮肤直接接触,且在本发明中,还可在步骤(2)所述混合后,将混合物转移至特定形貌的模具中进行交联反应,制备得到具有特定形状的医用粘合胶。此外,在实施例中,为了清晰地表征粘合胶的贴合性能,可以在混合溶液A中加入亚甲基蓝(0.01-0.1份)进行染色,使制得的粘合胶呈现蓝色。It should be noted that the use of the alkaline buffer can adjust the pH of the mixed solution described in step (2) to 6-7, which can be in direct contact with the skin, and in the present invention, it can also be used in step (2). ) after mixing, the mixture is transferred to a mold with a specific shape for cross-linking reaction, and a medical adhesive with a specific shape is prepared. In addition, in the embodiment, in order to clearly characterize the bonding performance of the adhesive, methylene blue (0.01-0.1 part) can be added to the mixed solution A for dyeing, so that the prepared adhesive appears blue.
作为本发明的优选技术方案,所述混合溶液A的质量百分含量为6-50%,例如可以是6%、10%、15%、20%、25%、30%、35%、40%、45%或50%等。As a preferred technical solution of the present invention, the mass percentage of the mixed solution A is 6-50%, such as 6%, 10%, 15%, 20%, 25%, 30%, 35%, 40% , 45% or 50% etc.
优选地,所述混合溶液B的质量百分含量为5-30%,例如可以是5%、7%、10%、12%、15%、18%、20%、22%、25%、27%或30%等。Preferably, the mass percentage of the mixed solution B is 5-30%, such as 5%, 7%, 10%, 12%, 15%, 18%, 20%, 22%, 25%, 27% % or 30% etc.
作为本发明的优选技术方案,步骤(2)所述交联反应选自热交联反应或光交联反应。As a preferred technical solution of the present invention, the crosslinking reaction in step (2) is selected from thermal crosslinking reaction or photocrosslinking reaction.
需要说明的是,若步骤(2)中加入的引发剂为热引发剂,则步骤(2)进行热交联反应;若步骤(2)中加入的交联剂为光引发剂,则步骤(2)进行光交联反应。It should be noted that if the initiator added in step (2) is a thermal initiator, then step (2) carries out thermal crosslinking reaction; if the crosslinking agent added in step (2) is a photoinitiator, then step ( 2) Carry out photocrosslinking reaction.
优选地,所述热交联反应的温度为60-80℃,例如可以是60℃、62℃、64℃、66℃、68℃、70℃、72℃、74℃、76℃、78℃或80℃等。Preferably, the temperature of the thermal crosslinking reaction is 60-80°C, such as 60°C, 62°C, 64°C, 66°C, 68°C, 70°C, 72°C, 74°C, 76°C, 78°C or 80°C etc.
优选地,所述光交联反应为在紫外光下进行交联反应。Preferably, the photocrosslinking reaction is carried out under ultraviolet light.
优选地,所述交联反应的时间为0.5-60min,例如可以是0.5min、1min、2min、5min、7min、10min、12min、15min、18min、20min、23min、25min、27min、30min、40min、50min或60min等。Preferably, the time of the cross-linking reaction is 0.5-60min, such as 0.5min, 1min, 2min, 5min, 7min, 10min, 12min, 15min, 18min, 20min, 23min, 25min, 27min, 30min, 40min, 50min or 60min etc.
优选地,步骤(2)所述混合后还包括后处理的步骤。Preferably, after the mixing in step (2), a post-processing step is also included.
优选地,所述后处理的方法为超声除氧。Preferably, the post-treatment method is ultrasonic deoxygenation.
本发明中,通过在步骤(2)所述混合后进行超声除氧操作,可除去混合物中的氧气,避免氧气的存在影响后续的交联反应,若不进行除氧操作,最终制备得到的医用粘合胶的成胶效果较差,甚至不能成胶。In the present invention, by performing the ultrasonic deoxygenation operation after the mixing described in step (2), the oxygen in the mixture can be removed to avoid the influence of the presence of oxygen on the subsequent crosslinking reaction. If the deoxygenation operation is not performed, the final prepared medical The gelling effect of the adhesive glue is poor, and even cannot be gelled.
作为本发明的优选技术方案,所述制备方法具体包括如下步骤:As a preferred technical solution of the present invention, the preparation method specifically includes the following steps:
(1)将丙烯酸酯类聚乙二醇、丙烯酸类化合物、交联剂和水混合均匀,得到质量百分含量为6-50%的混合溶液A;(1) uniformly mixing acrylate polyethylene glycol, acrylic compound, crosslinking agent and water to obtain a mixed solution A with a mass percentage of 6-50%;
将任选的增稠剂和水混合均匀,得到质量百分含量为5-30%混合溶液的B;Mix the optional thickener and water evenly to obtain B with a mass percent content of 5-30% mixed solution;
(2)将步骤(1)得到的混合溶液A、混合溶液B、缓冲剂溶液和引发剂混合均匀后,经超声除氧后进行交联,得到所述医用粘合胶。(2) Mix the mixed solution A, mixed solution B, buffer solution and initiator obtained in the step (1) uniformly, and carry out cross-linking after ultrasonic deoxygenation to obtain the medical adhesive.
第三方面,本发明提供一种如第一方面所述的医用粘合胶的应用,所述应用包括所述医用粘合胶用作创面止血材料、内脏及软组织伤口封合和堵漏材料、纤维环断裂的修复材料或组织工程的药物载体材料。In a third aspect, the present invention provides an application of the medical adhesive glue as described in the first aspect, the application includes that the medical adhesive glue is used as a wound hemostatic material, visceral and soft tissue wound sealing and plugging material, Repair materials for fibrous annulus rupture or drug carrier materials for tissue engineering.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明通过对医用粘合胶原料组分的设计,制备得到的医用粘合胶既具有较高的粘附强度,可瞬时黏附组织,其粘附强度为40-88N/m,又具有较好的弯曲贴合性,能够紧密贴合组织关节,同时具有生物相容性和生物可降解性能,对生物体无毒副作用,适用于创面止血、内脏及软组织伤口封合和堵漏、纤维环断裂的修复或组织工程的药物载体。In the present invention, through the design of the raw material components of the medical adhesive glue, the prepared medical adhesive glue not only has relatively high adhesion strength, but can instantly adhere to tissues, and its adhesion strength is 40-88N/m, and has better Excellent bending fit, can be closely attached to tissue joints, and has biocompatibility and biodegradability, has no toxic and side effects on organisms, and is suitable for wound hemostasis, visceral and soft tissue wound sealing and plugging, and fibrous annulus rupture Drug carrier for repair or tissue engineering.
附图说明Description of drawings
图1是本发明实施例1制得的医用粘合胶进行粘附贴合性测试的实物图;Fig. 1 is the physical figure that the medical adhesive glue that the embodiment 1 of the present invention makes carries out the adhesion fit test;
图2是本发明实施例4制得的医用粘合胶进行柔韧弯曲形变测试的实物图;Fig. 2 is the physical picture of the flexible bending deformation test of the medical adhesive glue prepared in Example 4 of the present invention;
图3是本发明实施例5制得的医用粘合胶进行粘附贴合性测试的实物图。Fig. 3 is an actual picture of the adhesion test of the medical adhesive prepared in Example 5 of the present invention.
具体实施方式Detailed ways
下面结合附图并通过具体实施方式来进一步说明本发明的技术方案。本领域技术人员应该明了,所述实施例仅仅是帮助理解本发明,不应视为对本发明的具体限制。The technical solutions of the present invention will be further described below in conjunction with the accompanying drawings and through specific implementation methods. It should be clear to those skilled in the art that the examples are only for helping to understand the present invention, and should not be regarded as specific limitations on the present invention.
下述实施例和对比例中部分原料组分来源如下:Part raw material component source is as follows in following embodiment and comparative example:
聚乙二醇甲醚甲基丙烯酸酯:Sigma-Aldrich;Polyethylene glycol methyl ether methacrylate: Sigma-Aldrich;
聚乙二醇甲基丙烯酸酯:湖南华腾制药有限公司;Polyethylene glycol methacrylate: Hunan Huateng Pharmaceutical Co., Ltd.;
聚乙二醇二丙烯酸酯:Sigma-Aldrich;Polyethylene glycol diacrylate: Sigma-Aldrich;
甲氧基聚乙二醇丙烯酸酯:上海西格生物科技有限公司;Methoxy polyethylene glycol acrylate: Shanghai Sig Biotechnology Co., Ltd.;
聚乙二醇二甲基丙烯酸酯:Sigma-Aldrich;Polyethylene glycol dimethacrylate: Sigma-Aldrich;
明胶:Sigma-Aldrich;Gelatin: Sigma-Aldrich;
海藻酸钠:上海麦克林生化科技有限公司。Sodium alginate: Shanghai McLean Biochemical Technology Co., Ltd.
实施例1Example 1
本实施例提供一种医用粘合胶及其制备方法,其制备原料包括如下重量份数的组分:聚乙二醇甲醚甲基丙烯酸酯29.8份、丙烯酸0.2份、聚乙二醇二丙烯酸酯0.01份、氢氧化钠溶液0.1份、明胶5份、过硫酸铵0.05份、亚甲基蓝0.01份和水64份;This embodiment provides a medical adhesive and its preparation method. The raw materials for its preparation include the following components in parts by weight: 29.8 parts of polyethylene glycol methyl ether methacrylate, 0.2 parts of acrylic acid, polyethylene glycol diacrylic acid 0.01 part of ester, 0.1 part of sodium hydroxide solution, 5 parts of gelatin, 0.05 part of ammonium persulfate, 0.01 part of methylene blue and 64 parts of water;
所述氢氧化钠溶液的质量百分含量为20%。The mass percentage of the sodium hydroxide solution is 20%.
上述医用粘合胶的制备方法如下:The preparation method of above-mentioned medical adhesive glue is as follows:
(1)将聚乙二醇甲醚甲基丙烯酸酯、丙烯酸、聚乙二醇二丙烯酸酯、亚甲基蓝和水混合均匀,得到质量百分含量为30%的混合溶液A;(1) Mix polyethylene glycol methyl ether methacrylate, acrylic acid, polyethylene glycol diacrylate, methylene blue and water evenly to obtain a mixed solution A with a mass percentage of 30%;
将明胶和水混合均匀,得到质量百分含量为5%的混合溶液B;Mix the gelatin and water evenly to obtain a mixed solution B with a mass percentage of 5%;
(2)将步骤(1)得到的混合溶液A、混合溶液B、氢氧化钠溶液和过硫酸铵混合均匀后,经超声除氧后,加热至70℃进行交联反应25min,得到所述医用粘合胶。(2) After mixing the mixed solution A, mixed solution B, sodium hydroxide solution and ammonium persulfate obtained in step (1) uniformly, after deoxygenation by ultrasonic waves, heat to 70°C for cross-linking reaction for 25 minutes to obtain the medical Adhesive glue.
对本实施例制备得到的医用粘合胶进行贴合性测试,如图1所示,将本实施例提供的医用粘合胶裁剪为8cm×1.5cm的长条带,将其贴附于弯曲度为120°的钢尺上,由图1可知,医用粘合胶可与钢尺紧密地粘附贴合,说明其贴合性较好。Carry out the fit test on the medical adhesive glue prepared in this example, as shown in Figure 1, cut the medical adhesive glue provided in this example into a long strip of 8cm×1.5cm, and attach it to the On the steel ruler with a 120° angle, it can be seen from Figure 1 that the medical adhesive can be closely adhered to the steel ruler, indicating that its fit is good.
实施例2Example 2
本实施例提供一种医用粘合胶及其制备方法,其制备原料包括如下重量份数的组分:聚乙二醇甲基丙烯酸酯6份、甲基丙烯酸35份、N,N-亚甲基双丙烯酰胺0.1份、碱性缓冲剂溶液0.1份、海藻酸钠5份、2-羟基-4-(2-羟乙氧基)-2-甲基苯丙酮0.01份和水52份;This example provides a medical adhesive and its preparation method. The preparation raw materials include the following components in parts by weight: 6 parts of polyethylene glycol methacrylate, 35 parts of methacrylic acid, N,N-methylene 0.1 part of bisacrylamide, 0.1 part of alkaline buffer solution, 5 parts of sodium alginate, 0.01 part of 2-hydroxy-4-(2-hydroxyethoxy)-2-methylpropiophenone and 52 parts of water;
所述碱性缓冲剂由氢氧化钠和磷酸氢二钠按质量比3:1组成,碱性缓冲剂溶液的质量百分含量为20%。The alkaline buffer is composed of sodium hydroxide and disodium hydrogen phosphate in a mass ratio of 3:1, and the mass percentage of the alkaline buffer solution is 20%.
上述医用粘合胶的制备方法如下:The preparation method of above-mentioned medical adhesive glue is as follows:
(1)将聚乙二醇甲基丙烯酸酯、甲基丙烯酸、N,N-亚甲基双丙烯酰胺和水混合均匀,得到质量百分含量为45%的混合溶液A;(1) Mix polyethylene glycol methacrylate, methacrylic acid, N,N-methylenebisacrylamide and water evenly to obtain a mixed solution A with a mass percentage of 45%;
将海藻酸钠和水混合均匀,得到质量百分含量为10%的混合溶液B;Mix sodium alginate and water evenly to obtain a mixed solution B with a mass percentage of 10%;
(2)将步骤(1)得到的混合溶液A、混合溶液B、碱性缓冲剂溶液和2-羟基-4-(2-羟乙氧基)-2-甲基苯丙酮混合均匀后,经超声除氧后,在功率为2000W的紫外汞灯照射下,进行光交联1min,得到所述医用粘合胶。(2) After the mixed solution A, mixed solution B, alkaline buffer solution and 2-hydroxyl-4-(2-hydroxyethoxy)-2-methyl propiophenone obtained in step (1) are mixed uniformly, After ultrasonic deoxygenation, under the irradiation of an ultraviolet mercury lamp with a power of 2000W, photocrosslinking was carried out for 1 min to obtain the medical adhesive.
实施例3Example 3
本实施例提供一种医用粘合胶及其制备方法,其制备原料包括如下重量份数的组分:甲氧基聚乙二醇丙烯酸酯50份、丙烯酸5份、聚乙二醇二甲基丙烯酸酯0.01份、碳酸氢钠溶液3份、明胶3份、过硫酸钾0.01份和水42份;This embodiment provides a kind of medical adhesive glue and its preparation method, and its preparation raw material comprises the following components in parts by weight: 50 parts of methoxypolyethylene glycol acrylate, 5 parts of acrylic acid, polyethylene glycol dimethyl 0.01 part of acrylate, 3 parts of sodium bicarbonate solution, 3 parts of gelatin, 0.01 part of potassium persulfate and 42 parts of water;
所述碳酸氢钠溶液的质量百分含量为30%。The mass percentage of the sodium bicarbonate solution is 30%.
上述医用粘合胶的制备方法如下:The preparation method of above-mentioned medical adhesive glue is as follows:
(1)将甲氧基聚乙二醇丙烯酸酯、丙烯酸、聚乙二醇二甲基丙烯酸酯和水混合均匀,得到质量百分含量为55%的混合溶液A;(1) Mix methoxypolyethylene glycol acrylate, acrylic acid, polyethylene glycol dimethacrylate and water evenly to obtain a mixed solution A with a mass percentage of 55%;
将明胶和水混合均匀,得到质量百分含量为15%的混合溶液B;Mix the gelatin and water evenly to obtain a mixed solution B with a mass percentage of 15%;
(2)将步骤(1)得到的混合溶液A、混合溶液B、碳酸氢钠溶液和过硫酸钾混合均匀后,经超声除氧后,加热至65℃进行交联反应30min,得到所述医用粘合胶。(2) After mixing the mixed solution A, mixed solution B, sodium bicarbonate solution and potassium persulfate obtained in step (1) evenly, after deoxygenation by ultrasonic waves, heat to 65°C for 30 minutes for cross-linking reaction to obtain the medical Adhesive glue.
实施例4Example 4
本实施例提供一种医用粘合胶及其制备方法,其制备原料包括如下重量份数的组分:甲氧基聚乙二醇丙烯酸酯20份、2-乙基丙烯酸10份、N,N-亚甲基双丙烯酰胺0.01份、碱性缓冲剂溶液1份、海藻酸钠15份、过硫酸铵0.1份和水55份;This embodiment provides a medical adhesive and its preparation method. The raw materials for its preparation include the following components in parts by weight: 20 parts of methoxypolyethylene glycol acrylate, 10 parts of 2-ethylacrylic acid, N,N - 0.01 part of methylenebisacrylamide, 1 part of alkaline buffer solution, 15 parts of sodium alginate, 0.1 part of ammonium persulfate and 55 parts of water;
所述碱性缓冲剂由磷酸氢二钠和氢氧化钠以质量比为1:2组成,碱性缓冲剂溶液的中碱性缓冲剂的质量百分含量为15%。The alkaline buffer is composed of disodium hydrogen phosphate and sodium hydroxide with a mass ratio of 1:2, and the mass percentage of the alkaline buffer in the alkaline buffer solution is 15%.
上述医用粘合胶的制备方法如下:The preparation method of above-mentioned medical adhesive glue is as follows:
(1)将甲氧基聚乙二醇丙烯酸酯、2-乙基丙烯酸、N,N-亚甲基双丙烯酰胺和水混合均匀,得到质量百分含量为30%的混合溶液A;(1) Mix methoxypolyethylene glycol acrylate, 2-ethylacrylic acid, N,N-methylenebisacrylamide and water evenly to obtain a mixed solution A with a mass percentage of 30%;
将海藻酸钠和水混合均匀,得到质量百分含量为15%混合溶液B;Mix sodium alginate and water evenly to obtain a mixed solution B with a mass percentage of 15%;
(2)将步骤(1)得到的混合溶液A、混合溶液B、碱性缓冲剂溶液和过硫酸铵混合均匀后,经超声除氧后,加热至70℃进行交联反应30min,得到所述医用粘合胶。(2) After mixing the mixed solution A, mixed solution B, alkaline buffer solution and ammonium persulfate obtained in step (1) uniformly, after ultrasonic deoxygenation, heat to 70° C. for 30 minutes for cross-linking reaction to obtain the described Medical adhesive.
对本实施例制备得到的医用粘合胶进行柔韧弯曲性测试,如图2所示,本实施例提供的医用粘合胶可以弯曲360°形成圆环并维持此稳定形状,说明医用粘合胶具备优异的柔韧弯曲形变的性能。The medical adhesive prepared in this embodiment was tested for flexibility and bendability. As shown in Figure 2, the medical adhesive provided in this embodiment can be bent 360° to form a ring and maintain this stable shape, indicating that the medical adhesive has Excellent flexible bending deformation performance.
实施例5Example 5
本实施例提供一种医用粘合胶及其制备方法,其制备原料包括如下重量份数的组分:聚乙二醇甲基丙烯酸酯10份、丙烯酸15份、乙二醇二甲基丙烯酸酯0.05份、氢氧化钠溶液0.3份、明胶8份、2-苄基-2-二甲基氨基-1-(4-吗啉苯基)丁酮0.05份、亚甲基蓝0.1份和水68份;This embodiment provides a medical adhesive and its preparation method. The raw materials for its preparation include the following components in parts by weight: 10 parts of polyethylene glycol methacrylate, 15 parts of acrylic acid, ethylene glycol dimethacrylate 0.05 parts, 0.3 parts of sodium hydroxide solution, 8 parts of gelatin, 0.05 parts of 2-benzyl-2-dimethylamino-1-(4-morpholine phenyl) butanone, 0.1 parts of methylene blue and 68 parts of water;
所述氢氧化钠溶液的质量百分含量为25%。The mass percentage of the sodium hydroxide solution is 25%.
上述医用粘合胶的制备方法如下:The preparation method of above-mentioned medical adhesive glue is as follows:
(1)将聚乙二醇甲基丙烯酸酯、丙烯酸、乙二醇二甲基丙烯酸酯和水混合均匀,得到质量百分含量为25%的混合溶液;(1) uniformly mixing polyethylene glycol methacrylate, acrylic acid, ethylene glycol dimethacrylate and water to obtain a mixed solution with a mass percentage of 25%;
(2)将步骤(1)得到的混合溶液、氢氧化钠溶液和2-苄基-2-二甲基氨基-1-(4-吗啉苯基)丁酮混合均匀后,经超声除氧后,在功率为2000W的紫外汞灯照射下,进行光交联2min,得到所述医用粘合胶。(2) After mixing the mixed solution obtained in step (1), sodium hydroxide solution and 2-benzyl-2-dimethylamino-1-(4-morpholine phenyl) butanone evenly, deoxygenate by ultrasonic Afterwards, under the irradiation of an ultraviolet mercury lamp with a power of 2000W, photocrosslinking was carried out for 2 minutes to obtain the medical adhesive.
对本实施例制备得到的医用粘合胶进行粘附贴合性测试,如图3所示,本实施例提供的医用粘合胶能够紧密地粘附于手部关节处,并跟随关节部位的弯曲呈现粘附贴合,说明医用粘合胶具备良好的粘附贴合性能。Adhesion and fit test was carried out on the medical adhesive prepared in this example, as shown in Figure 3, the medical adhesive provided in this example can adhere tightly to the joints of the hand and follow the bending of the joints Adhesive fit is present, indicating that the medical adhesive has good adhesion and fit performance.
实施例6Example 6
本实施例提供一种医用粘合胶及其制备方法,与实施例1的区别仅在于,聚乙二醇二丙烯酸酯的重量份数为0.001份;其他条件与实施例1相同。This embodiment provides a medical adhesive and its preparation method. The only difference from Embodiment 1 is that the weight part of polyethylene glycol diacrylate is 0.001 part; other conditions are the same as Embodiment 1.
实施例7Example 7
本实施例提供一种医用粘合胶及其制备方法,与实施例1的区别仅在于,聚乙二醇二丙烯酸酯的重量份数为1份;其他条件与实施例1相同。This embodiment provides a medical adhesive and its preparation method. The only difference from Embodiment 1 is that the weight part of polyethylene glycol diacrylate is 1 part; other conditions are the same as Embodiment 1.
对比例1Comparative example 1
本对比例提供一种医用粘合胶及其制备方法,与实施例1的区别仅在于,,聚乙二醇二丙烯酸酯的重量份数为1.2份;其他条件与实施例1相同。This comparative example provides a medical adhesive and its preparation method. The only difference from Example 1 is that the weight part of polyethylene glycol diacrylate is 1.2 parts; other conditions are the same as Example 1.
对比例2Comparative example 2
本对比例提供一种医用粘合胶及其制备方法,与实施例1的区别仅在于,所述医用粘合胶的原料组分中不含聚乙二醇甲醚甲基丙烯酸酯,丙烯酸类的重量份数为30份;其他条件与实施例1相同。This comparative example provides a kind of medical adhesive glue and its preparation method. The difference from Example 1 is that the raw material components of the medical adhesive glue do not contain polyethylene glycol methyl ether methacrylate, acrylic acid The parts by weight are 30 parts; Other conditions are identical with embodiment 1.
对比例3Comparative example 3
本对比例提供一种医用粘合胶及其制备方法,与实施例1的区别仅在于,所述医用粘合胶的原料组分中不含丙烯酸,聚乙二醇甲醚甲基丙烯酸酯的重量份数为30份;其他条件与实施例1相同。This comparative example provides a kind of medical adhesive glue and preparation method thereof, and the difference with embodiment 1 is only, the raw material component of described medical adhesive glue does not contain acrylic acid, polyethylene glycol methyl ether methacrylate Parts by weight are 30 parts; Other conditions are the same as in Example 1.
对上述实施例和对比例提供的医用粘合胶的性能进行测试,测试标准如下:The performance of the medical adhesive provided by the above-mentioned embodiment and comparative example is tested, and the test standard is as follows:
粘附强度:按照T-剥离试验(ASTM D903)用于测试柔韧性粘合胶从较硬基材上进行剥离的粘附测试方法从而进行测试。Adhesion Strength: Tested according to the T-Peel Test (ASTM D903) Adhesion Test Method for Testing the Peeling of Flexible Adhesives from Harder Substrates.
上述实施例和对比例提供的医用粘合胶性能的测试结果如表1所示:The test result of the medical adhesive glue performance that above-mentioned embodiment and comparative example provide are as shown in table 1:
表1Table 1
由表1与图1-3可知,本发明通过对医用粘合胶原料组分的设计,制备得到的医用粘合胶既具有较高的粘附强度,可瞬时黏附组织,其粘附强度为40-88N/m,又具有较好的弯曲贴合性,能够紧密贴合组织关节,同时具有生物相容性和生物可降解性能,对生物体无毒副作用,适用于创面止血、内脏及软组织伤口封合和堵漏、纤维环断裂的修复或组织工程的药物载体。It can be seen from Table 1 and Figures 1-3 that the medical adhesive prepared by the present invention has a high adhesive strength and can instantly adhere to tissues through the design of the raw material components of the medical adhesive. The adhesive strength is 40-88N/m, and has good bending fit, can closely fit tissue joints, has biocompatibility and biodegradability, has no toxic and side effects on organisms, and is suitable for wound hemostasis, internal organs and soft tissues Wound sealing and plugging, repair of annulus fibrosus rupture or drug carrier for tissue engineering.
与实施例1相比,若医用粘合胶的制备原料中交联剂的含量过大(对比例1),则制备得到的医用粘合胶的粘附强度较低为30N/m;若医用粘合胶的制备原料中不含丙烯酸酯类聚乙二醇(对比例2)或不含丙烯酸类化合物(对比例3),则制备得到的粘附强度也偏低。由此可知,本申请通过对医用粘合胶的制备原料组分及含量的设计,能够制备得到具有较高粘附强度的医用粘合胶。Compared with Example 1, if the content of cross-linking agent in the preparation raw material of medical adhesive glue is too large (comparative example 1), then the adhesive strength of the medical adhesive glue prepared is as low as 30N/m; If the raw materials for the preparation of the adhesive do not contain acrylate-based polyethylene glycol (comparative example 2) or acrylic compounds (comparative example 3), the prepared adhesive strength is also low. It can be seen that the present application can prepare medical adhesives with higher adhesive strength by designing the raw material components and contents for the preparation of medical adhesives.
申请人声明,本发明通过上述实施例来说明本发明的详细工艺流程,但本发明并不局限于上述详细工艺流程,即不意味着本发明必须依赖上述详细工艺流程才能实施。所属技术领域的技术人员应该明了,对本发明的任何改进,对本发明产品各原料的等效替换及辅助成分的添加、具体方式的选择等,均落在本发明的保护范围和公开范围之内。The applicant declares that the present invention illustrates the detailed process flow of the present invention through the above-mentioned examples, but the present invention is not limited to the above-mentioned detailed process flow, that is, it does not mean that the present invention must rely on the above-mentioned detailed process flow to be implemented. Those skilled in the art should understand that any improvement of the present invention, the equivalent replacement of each raw material of the product of the present invention, the addition of auxiliary components, the selection of specific methods, etc., all fall within the scope of protection and disclosure of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110529414.3A CN115337442A (en) | 2021-05-14 | 2021-05-14 | A kind of medical adhesive glue and its preparation method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110529414.3A CN115337442A (en) | 2021-05-14 | 2021-05-14 | A kind of medical adhesive glue and its preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115337442A true CN115337442A (en) | 2022-11-15 |
Family
ID=83947193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110529414.3A Pending CN115337442A (en) | 2021-05-14 | 2021-05-14 | A kind of medical adhesive glue and its preparation method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115337442A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115970048A (en) * | 2023-02-24 | 2023-04-18 | 海孵(海南自贸区)医疗科技有限责任公司 | High-moisture-retention polyethylene glycol liquid dressing and preparation method thereof |
CN117860952A (en) * | 2024-03-12 | 2024-04-12 | 颢箔医疗科技(上海)有限公司 | Adhesive material and application thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002356661A (en) * | 2001-05-30 | 2002-12-13 | Nippon Koden Corp | Pressure sensitive-adhesive composition, method for manufacturing the same, and bioelectric electrodes using the same |
CN101087860A (en) * | 2004-12-03 | 2007-12-12 | 3M创新有限公司 | Process for making pressure sensitive adhesive hydrogels |
CN101955744A (en) * | 2009-07-16 | 2011-01-26 | Lg化学株式会社 | Acrylic pressure sensitive adhesive and method of preparing the same |
CN105169465A (en) * | 2015-07-13 | 2015-12-23 | 广州新诚生物科技有限公司 | Medical anti-adhesion hydrogel dressing and preparation method thereof |
CN111150878A (en) * | 2018-11-07 | 2020-05-15 | 财团法人工业技术研究院 | Biodegradable sealant and its use |
CN112391131A (en) * | 2020-11-16 | 2021-02-23 | 中山市皇冠胶粘制品有限公司 | Environment-friendly water-soluble acrylate pressure-sensitive adhesive, adhesive tape and preparation method and application thereof |
-
2021
- 2021-05-14 CN CN202110529414.3A patent/CN115337442A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002356661A (en) * | 2001-05-30 | 2002-12-13 | Nippon Koden Corp | Pressure sensitive-adhesive composition, method for manufacturing the same, and bioelectric electrodes using the same |
CN101087860A (en) * | 2004-12-03 | 2007-12-12 | 3M创新有限公司 | Process for making pressure sensitive adhesive hydrogels |
CN101955744A (en) * | 2009-07-16 | 2011-01-26 | Lg化学株式会社 | Acrylic pressure sensitive adhesive and method of preparing the same |
CN105169465A (en) * | 2015-07-13 | 2015-12-23 | 广州新诚生物科技有限公司 | Medical anti-adhesion hydrogel dressing and preparation method thereof |
CN111150878A (en) * | 2018-11-07 | 2020-05-15 | 财团法人工业技术研究院 | Biodegradable sealant and its use |
CN112391131A (en) * | 2020-11-16 | 2021-02-23 | 中山市皇冠胶粘制品有限公司 | Environment-friendly water-soluble acrylate pressure-sensitive adhesive, adhesive tape and preparation method and application thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115970048A (en) * | 2023-02-24 | 2023-04-18 | 海孵(海南自贸区)医疗科技有限责任公司 | High-moisture-retention polyethylene glycol liquid dressing and preparation method thereof |
CN115970048B (en) * | 2023-02-24 | 2024-06-11 | 海孵(海南自贸区)医疗科技有限责任公司 | Polyethylene glycol liquid dressing with high moisture retention and preparation method thereof |
CN117860952A (en) * | 2024-03-12 | 2024-04-12 | 颢箔医疗科技(上海)有限公司 | Adhesive material and application thereof |
CN117860952B (en) * | 2024-03-12 | 2024-05-24 | 颢箔医疗科技(上海)有限公司 | Adhesive material and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4876073B2 (en) | Tissue adhesive material | |
Liu et al. | Bio‐inspired self‐hydrophobized sericin adhesive with tough underwater adhesion enables wound healing and fluid leakage sealing | |
JP6678101B2 (en) | Hydrophobic tissue adhesive | |
CN107626002B (en) | Response type medical gel and preparation method and application thereof | |
CN114712550B (en) | Hydrogel adhesive capable of being injected for rapid hemostasis and preparation method and application thereof | |
CN113368312B (en) | Preparation method and application of biodegradable self-adhesive hydrogel | |
US8846849B2 (en) | Tissue sealants from plasma derived proteins | |
CN107496974A (en) | A kind of two-component adhesive of medical based on glucan and chitosan and preparation method thereof | |
CN113663117B (en) | A kind of anti-swelling biological adhesive and its preparation method and application | |
CN115337442A (en) | A kind of medical adhesive glue and its preparation method and application | |
CN112876597B (en) | A kind of cross-linking agent, bioadhesive and its preparation method and application | |
US20240238477A1 (en) | Self-adhesive absorbable biological patch and preparation method and use thereof | |
Kong et al. | Tissue adhesives for wound closure | |
CN114736397A (en) | Preparation method and application of wet adhesive hydrogel for dura mater injury repair | |
CN114209874A (en) | Medical hydrogel adhesive and preparation method and application thereof | |
CN113577370A (en) | Janus hydrogel adhesive and preparation method and application thereof | |
CN116693931A (en) | A superstructure porous wet adhesive hydrogel and its preparation method and application | |
CN115746388B (en) | Self-adhesion hemostatic repair gel containing multi-scale pore network, and preparation method and application thereof | |
CN104888268B (en) | Cyanoacrylate adhesive and its preparation method | |
CN108619560B (en) | A kind of preparation method of tissue adhesion hemostatic antibacterial nano film | |
CN118542964A (en) | A tissue sealant patch and preparation method thereof | |
Ferreira et al. | An overview in surgical adhesives | |
CN118203690A (en) | Medical glue for long-term bonding of wet tissue and preparation method thereof | |
CN114644766B (en) | A kind of temperature-sensitive debonding wet tissue adhesion hydrogel and preparation method thereof | |
CN113384739B (en) | Biological glue product for rapid hemostasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221115 |